New cancer clinical trial: Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy

Published on: July 31, 2018 at 12:00PM
Conditions:   Epithelial Ovarian Cancer;   Primary Peritoneal Carcinoma;   Fallopian Tube Cancer
Interventions:   Drug: AVB-S6-500;   Drug: Paclitaxel;   Drug: Carboplatin;   Procedure: Tissue from Diagnostic Laparoscopy;   Procedure: Tissue from Core biopsy;   Procedure: Interval Debulking;   Procedure: Peripheral blood;   Procedure: Ascites collection
Sponsors:   Washington University School of Medicine;   Aravive Biologics
Not yet recruiting
https://ift.tt/2mZK2b5